UPDATE: Oppenheimer Lowers PT on Medtronic from $48 to $42


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Oppenheimer has published a research report on Medtronic (NYSE: MDT) lowering the price target.In the report, Oppenheimer wrote, "On MDT's F1Q call, mgmt noted continued ICD/Spine pressures, reiterated FY12 guidance on solid performance from its remaining business lines/cost savings, anddiscussed new CEO Omar Ishrak's priorities for reinvigorating growth."Oppenheimer rated Medtronic an Outperform with a price target lowered from $48.00 to $42.00. Medtronic closed Tuesday at $33.10.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareHealth Care EquipmentOppenheimer